| GATA2 | K562 (myelogenous leukemia) | bio | Permissive
      
      Robust | Homo sapiens | GSE29195
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | K562 (myelogenous leukemia) | bmp | Permissive
      
      Robust | Homo sapiens | GSE29195
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | G1E-ER4 (embryonic stem cells) | E2 | Permissive | Mus musculus | GSE30142
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | G1E-ER4 (embryonic stem cells) | 24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison) | Permissive | Mus musculus | ENCSR000DID
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | uterus | P4 | Permissive
      
      Robust | Mus musculus | GSE40659
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | embryonic stem cell-derived hemangioblasts | none | Permissive | Mus musculus | GSE69099
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | embryonic stem cell-derived hematopoietic progenitors | none | Permissive | Mus musculus | GSE69099
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | Lhx2 (hematopoietic stem cells) | TGFb | Permissive
      
      Robust | Mus musculus | GSE73641
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive) | RUNX1-EVI1 KD | Permissive
      
      Robust | Homo sapiens | GSE87283
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | WA09 (embryonic stem cells) | BMP4 for 3 day | Permissive | Homo sapiens | GSE105081
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | WA09 (embryonic stem cells) | BMP4 for 3 day | Permissive
      
      Robust | Homo sapiens | GSE105081
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | HUVEC-C (HUVEC, umbilical vein endothelial cells) | Treatment: agent VEGF, timepoint 0 Passage: P3-6 | Permissive
      
      Robust | Homo sapiens | GSE109625
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | HUVEC-C (HUVEC, umbilical vein endothelial cells) | Treatment: agent VEGF, timepoint 1 Passage: P3-6 | Permissive
      
      Robust | Homo sapiens | GSE109625
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | HUVEC-C (HUVEC, umbilical vein endothelial cells) | Treatment: agent VEGF, timepoint 4 Passage: P3-6 | Permissive
      
      Robust | Homo sapiens | GSE109625
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | HUVEC-C (HUVEC, umbilical vein endothelial cells) | Treatment: agent VEGF, timepoint 12 Passage: P3-6 | Permissive
      
      Robust | Homo sapiens | GSE109625
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | 3T3-L1 (embryonic fibroblasts) | PAssage: 4-6 | Permissive
      
      Robust | Mus musculus | GSE101592
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | 3T3-L1 (embryonic fibroblasts) | PAssage: 4-6 | Permissive
      
      Robust | Mus musculus | GSE101592
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | C3H10T1/2 (embryonic fibroblasts) | PAssage: 4-6 | Permissive
      
      Robust | Mus musculus | GSE101592
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | TF-1 (erythroleukemia) | Genotype: wildtype; Treatment: DOX for 6 days; | Permissive
      
      Robust | Homo sapiens | GSE73207
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | TF-1 (erythroleukemia) | Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days; | Permissive | Homo sapiens | GSE73207
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | TF-1 (erythroleukemia) | Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days; | Permissive | Homo sapiens | GSE73207
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | ME-1 (acute myeloid leukemia ) | Treatment: 600 ng/ml doxycycline; Genotype: CBFB-MYH11 knockdown construct, GATA2 knockdown; | Permissive | Homo sapiens | GSE117138
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000BKM | MA0036.3 | 
  
    
    | GATA2 | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000DKA | MA0036.3 | 
  
    
    | GATA2 | HUVEC-C (HUVEC, umbilical vein endothelial cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000EVW | MA0036.3 | 
  
    
    | GATA2 | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000EWG | MA0036.3 | 
  
    
    | GATA2 | SH-SY5Y (neuroblastoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000EYB | MA0036.3 | 
  
    
    | GATA2 | Lin- bone marrow hematopoietic progenitor cells |  | Permissive
      
      Robust | Mus musculus | GSE26031
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | embryonic stem cell-derived haematopoietic cells |  | Permissive
      
      Robust | Mus musculus | GSE22178
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | megakaryocytes |  | Permissive
      
      Robust | Homo sapiens | GSE24674
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | G1E (embryonic stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE29193
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | GSE18868
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | HUVEC-C (HUVEC, umbilical vein endothelial cells) |  | Permissive
      
      Robust | Homo sapiens | GSE29531
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | G1E (embryonic stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE30142
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | G1E (embryonic stem cells) |  | Permissive | Mus musculus | ENCSR000DIE
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | mast cells |  | Permissive
      
      Robust | Mus musculus | GSE42518
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | G1ME (megakaryocyte progenitor cell line) |  | Permissive
      
      Robust | Mus musculus | GSE31331
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | CD34+ hematopoietic stem cells |  | Permissive
      
      Robust | Homo sapiens | GSE45144
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | FDCP-Mix (multipotent stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE50406
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | FDCP-Mix (multipotent stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE50406
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | FDCP-Mix (multipotent stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE50406
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | FDCP-Mix (multipotent stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE50406
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | FDCP-Mix (multipotent stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE50406
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | FDCP-Mix (multipotent stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE50406
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | FDCP-Mix (multipotent stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE50406
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | mast cells |  | Permissive
      
      Robust | Mus musculus | GSE48085
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | 416B (hematopoietic precursor cells) |  | Permissive
      
      Robust | Mus musculus | GSE69776
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | Kasumi-3 (adult acute myeloid leukemia with minimal differentiation) |  | Permissive
      
      Robust | Homo sapiens | GSE84782
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | Kasumi-1 (acute myeloblastic leukemia) |  | Permissive | Homo sapiens | GSE76464
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | Hoxb8-FL |  | Permissive
      
      Robust | Mus musculus | GSE84328
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive) |  | Permissive
      
      Robust | Homo sapiens | GSE87283
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | endometrial stromal cells |  | Permissive
      
      Robust | Homo sapiens | GSE108408
              
            
          
            
            ... | MA0036.3 | 
  
    
    | GATA2 | HL-60 (acute myeloid leukemia) |  | Permissive | Homo sapiens | ERP008568 | MA0036.3 | 
  
    
    | GATA2 | LNCaP (prostate carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE38391 | MA0036.3 | 
  
    
    | GATA2 | ME-1 (acute myeloid leukemia ) |  | Permissive | Homo sapiens | GSE46044 | MA0036.3 | 
  
    
    | GATA2 | LNCaP (prostate carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE52725 | MA0036.3 | 
  
    
    | GATA2 | TSU-1621-MT (adult acute myeloid leukemia) |  | Permissive
      
      Robust | Homo sapiens | GSE60477 | MA0036.3 | 
  
    
    | GATA2 | TF-1 (erythroleukemia) |  | Permissive
      
      Robust | Homo sapiens | GSE73207 | MA0036.3 | 
  
    
    | GATA2 | CD34+ cells | ACY957 | Permissive
      
      Robust | Homo sapiens | GSE60792 | MA0036.3 | 
  
    
    | GATA2 | CD34+ cells | DMSO | Permissive
      
      Robust | Homo sapiens | GSE60792 | MA0036.3 | 
  
    
    | GATA2 | LNCaP (prostate carcinoma) | CSFCS | Permissive
      
      Robust | Homo sapiens | GSE69043 | MA0036.3 | 
  
    
    | GATA2 | LNCaP (prostate carcinoma) | ETOH | Permissive | Homo sapiens | GSE69043 | MA0036.3 | 
  
    
    | GATA2 | LNCaP (prostate carcinoma) | FBS | Permissive
      
      Robust | Homo sapiens | GSE69043 | MA0036.3 | 
  
    
    | GATA2 | LNCaP (prostate carcinoma) | R1881 | Permissive | Homo sapiens | GSE69043 | MA0036.3 | 
  
    
    | GATA2 | LNCaP (prostate carcinoma) | SHGATA2_ETOH | Permissive | Homo sapiens | GSE69043 | MA0036.3 | 
  
    
    | GATA2 | LNCaP (prostate carcinoma) | SHGATA2_R1881 | Permissive | Homo sapiens | GSE69043 | MA0036.3 |